VarmX
Develops a new treatment for severe bleeding
VarmX develops an innovative medicine for patients with severe, life-threatening bleeding. It focuses on people using anticoagulants for whom existing treatments are insufficient. The therapy is designed to quickly and effectively restore blood clotting without increasing the risk of new thrombosis. VarmX aims to improve safety and outcomes in the treatment of acute bleeding.
- Datum:
- 31-12-2017
- Locatie:
- Leiden
- Sector:
- Life Sciences & Health
- Fonds:
- InnovationQuarter Capital, UNIIQ
- Status:
- Active
- Website:
- https://varmx.com/
Related news about VarmX
Skip embedded content from YouTube
You can view this embedded content after you have accepted cookies from YouTube.
Embedded content from YouTube skipped.
Quickscan
Find out which fund fits your growth
In just 5 minutes